Global Glaucoma Eye Drops Market Research Report 2024

Publication ID:

PB505250139

Publication Date:

May 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Eye drops used in managing glaucoma decrease eye pressure by helping the eye鈥檚 fluid to drain better andor decreasing the amount of fluid made by the eye.
The global Glaucoma Eye Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glaucoma Eye Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glaucoma Eye Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glaucoma Eye Drops include Novartis, Allergan, Mylan and Bausch + Lomb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glaucoma Eye Drops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Eye Drops.
Report Scope
The Glaucoma Eye Drops market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glaucoma Eye Drops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glaucoma Eye Drops manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Allergan
Mylan
Bausch + Lomb
Segment by Type
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors (CAIs)
Rho Khinase Inhibitors
Segment by Application
Hospital Pharmacies
Optical Shop
Online Stores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glaucoma Eye Drops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glaucoma Eye Drops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Glaucoma Eye Drops Market Overview
1.1 Product Overview and Scope of Glaucoma Eye Drops
1.2 Glaucoma Eye Drops Segment by Type
1.2.1 Global Glaucoma Eye Drops Market Value Comparison by Type (2024-2030)
1.2.2 Prostaglandin Analogs
1.2.3 Beta Blockers
1.2.4 Alpha Agonists
1.2.5 Carbonic Anhydrase Inhibitors (CAIs)
1.2.6 Rho Khinase Inhibitors
1.3 Glaucoma Eye Drops Segment by Application
1.3.1 Global Glaucoma Eye Drops Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Optical Shop
1.3.4 Online Stores
1.3.5 Others
1.4 Global Glaucoma Eye Drops Market Size Estimates and Forecasts
1.4.1 Global Glaucoma Eye Drops Revenue 2019-2030
1.4.2 Global Glaucoma Eye Drops Sales 2019-2030
1.4.3 Global Glaucoma Eye Drops Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glaucoma Eye Drops Market Competition by Manufacturers
2.1 Global Glaucoma Eye Drops Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glaucoma Eye Drops Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glaucoma Eye Drops Average Price by Manufacturers (2019-2024)
2.4 Global Glaucoma Eye Drops Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glaucoma Eye Drops, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glaucoma Eye Drops, Product Type & Application
2.7 Glaucoma Eye Drops Market Competitive Situation and Trends
2.7.1 Glaucoma Eye Drops Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glaucoma Eye Drops Players Market Share by Revenue
2.7.3 Global Glaucoma Eye Drops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glaucoma Eye Drops Retrospective Market Scenario by Region
3.1 Global Glaucoma Eye Drops Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glaucoma Eye Drops Global Glaucoma Eye Drops Sales by Region: 2019-2030
3.2.1 Global Glaucoma Eye Drops Sales by Region: 2019-2024
3.2.2 Global Glaucoma Eye Drops Sales by Region: 2025-2030
3.3 Global Glaucoma Eye Drops Global Glaucoma Eye Drops Revenue by Region: 2019-2030
3.3.1 Global Glaucoma Eye Drops Revenue by Region: 2019-2024
3.3.2 Global Glaucoma Eye Drops Revenue by Region: 2025-2030
3.4 North America Glaucoma Eye Drops Market Facts & Figures by Country
3.4.1 North America Glaucoma Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glaucoma Eye Drops Sales by Country (2019-2030)
3.4.3 North America Glaucoma Eye Drops Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glaucoma Eye Drops Market Facts & Figures by Country
3.5.1 Europe Glaucoma Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glaucoma Eye Drops Sales by Country (2019-2030)
3.5.3 Europe Glaucoma Eye Drops Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glaucoma Eye Drops Market Facts & Figures by Country
3.6.1 Asia Pacific Glaucoma Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glaucoma Eye Drops Sales by Country (2019-2030)
3.6.3 Asia Pacific Glaucoma Eye Drops Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glaucoma Eye Drops Market Facts & Figures by Country
3.7.1 Latin America Glaucoma Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glaucoma Eye Drops Sales by Country (2019-2030)
3.7.3 Latin America Glaucoma Eye Drops Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glaucoma Eye Drops Market Facts & Figures by Country
3.8.1 Middle East and Africa Glaucoma Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glaucoma Eye Drops Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glaucoma Eye Drops Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glaucoma Eye Drops Sales by Type (2019-2030)
4.1.1 Global Glaucoma Eye Drops Sales by Type (2019-2024)
4.1.2 Global Glaucoma Eye Drops Sales by Type (2025-2030)
4.1.3 Global Glaucoma Eye Drops Sales Market Share by Type (2019-2030)
4.2 Global Glaucoma Eye Drops Revenue by Type (2019-2030)
4.2.1 Global Glaucoma Eye Drops Revenue by Type (2019-2024)
4.2.2 Global Glaucoma Eye Drops Revenue by Type (2025-2030)
4.2.3 Global Glaucoma Eye Drops Revenue Market Share by Type (2019-2030)
4.3 Global Glaucoma Eye Drops Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glaucoma Eye Drops Sales by Application (2019-2030)
5.1.1 Global Glaucoma Eye Drops Sales by Application (2019-2024)
5.1.2 Global Glaucoma Eye Drops Sales by Application (2025-2030)
5.1.3 Global Glaucoma Eye Drops Sales Market Share by Application (2019-2030)
5.2 Global Glaucoma Eye Drops Revenue by Application (2019-2030)
5.2.1 Global Glaucoma Eye Drops Revenue by Application (2019-2024)
5.2.2 Global Glaucoma Eye Drops Revenue by Application (2025-2030)
5.2.3 Global Glaucoma Eye Drops Revenue Market Share by Application (2019-2030)
5.3 Global Glaucoma Eye Drops Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Glaucoma Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Glaucoma Eye Drops Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Glaucoma Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Glaucoma Eye Drops Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Glaucoma Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Glaucoma Eye Drops Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Bausch + Lomb
6.4.1 Bausch + Lomb Corporation Information
6.4.2 Bausch + Lomb Description and Business Overview
6.4.3 Bausch + Lomb Glaucoma Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bausch + Lomb Glaucoma Eye Drops Product Portfolio
6.4.5 Bausch + Lomb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glaucoma Eye Drops Industry Chain Analysis
7.2 Glaucoma Eye Drops Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glaucoma Eye Drops Production Mode & Process
7.4 Glaucoma Eye Drops Sales and Marketing
7.4.1 Glaucoma Eye Drops Sales Channels
7.4.2 Glaucoma Eye Drops Distributors
7.5 Glaucoma Eye Drops Customers
8 Glaucoma Eye Drops Market Dynamics
8.1 Glaucoma Eye Drops Industry Trends
8.2 Glaucoma Eye Drops Market Drivers
8.3 Glaucoma Eye Drops Market Challenges
8.4 Glaucoma Eye Drops Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novartis
Allergan
Mylan
Bausch + Lomb

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂